AlphaCore Pharma Company Profile

News Articles [ 1211 Associated News Articles listed on BioPortfolio]

M&A: AstraZeneca acquires AlphaCore Pharma

AstraZeneca, a big pharma company, boosted its early-stage pipeline of experimental heart drugs on Wednesday by entering into an M&A deal and buying AlphaCore Pharma, which is developing a new typ...

[MedImmune] buys [AlphaCore] for early-stage cholesterol project

[AstraZeneca PLC]’s [MedImmune LLC] division has acquired private cardiovascular drug developer [AlphaCore Pharma].

MedImmune, AstraZeneca’s biologics unit, acquires AlphaCore Pharma

AstraZeneca announced that MedImmune has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company...

MedImmune aquires Alphacore Pharma

MedImmune, AstraZeneca’s global biologics R&D arm, has acquired AlphaCore Pharma, an Ann Arbor, Mich.-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-...

AstraZeneca Makes Good On Vow To Build CV Pipeline With AlphaCore Buy

AstraZeneca’s biologics unit MedImmune acquired AlphaCore Pharma, the developer of an early-stage asset with a novel mechanism for removing cholesterol from the body and raising “good” HDL chole...

EMA grants orphan drug status to AlphaCore FLD candidate

The European Medicines Agency (EMA) has granted orphan drug status to AlphaCore Pharma's ACP-501 (rhLCAT) to treat familial LCAT deficiency (FLD).

MedImmune, AstraZeneca's biologics unit, acquires AlphaCore Pharma

AstraZeneca today announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company focused on the develop...

AstraZeneca boosts cardiovascular-drug pipeline with AlphaCore buy

AstraZeneca's MedImmune unit agreed to purchase AlphaCore Pharma, a privately held U.S.  -More- Experience makes the difference: BioPharma Solutions, a business unit of Baxter, can help supp...

Drugs and Medications [ 238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [ 56 Associated PubMed Articles listed on BioPortfolio]

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Is pharma running out of brainy ideas?

Big pharma moves from 'blockbusters' to 'niche busters'.

China spurs pharma innovation.

Clinical Trials [ 35 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [ 590 Associated Companies listed on BioPortfolio]

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditi...

Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...